IGHE and Alzheimer disease: A 2019 clinical trial has investigated the trend of total and specific IgE levels (for extracts of Malassezia, for S. aureus enterotoxin, and for 112 allergens by ImmunoCAP ISAC multiplex assay) in 19 patients with AD treated with dupilumab.